Centenial Surgical Suture Ltd.
Snapshot View

56.70 +2.65 ▲4.9%

21 March 2023, 04:01:00 PM
Volume: 39

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.centenialindia.com
Market Cap 20.69 Cr.
Enterprise Value(EV) 19.22 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 2.61 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 21.68 Trailing Twelve Months Ending 2022-12
Industry PE 58.37 Trailing Twelve Months Ending 2022-12
Book Value / Share 80.30 Trailing Twelve Months Ending 2022-12
Price to Book Value 0.71 Calculated using Price: 56.70
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.36 Cr. 3,648,300 Shares
FaceValue 10
Company Profile
Centenial Surgical Suture Ltd., founded in 1995, manufactures a broad range of quality sterile needled sutures, with state-of-the-art manufacturing and packaging equipment, sophisticated processes designed and operated by Centenial's competent and devoted staff. Centenial Sutures is a combination of Craftmanship, the Latest Production Technology, Strictest Quality Control, Care and Dedication, results in Products of Incomparable Quality. Centenial is a company with a Surgeon's eye for Quality. At Centenial doing business the fair way is their Foremost Concern, by Guaranteeing Courteous, Fair and Honest Service, enough inventory to meet any order size and pricing. Centenial is confident that it can prove its flexibility, capacity and attention for Quality and Consistency in manufacturing world class sutures in India.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+4.90%
1 Week
+6.14%
1 Month
+12.50%
3 Month
+2.90%
6 Month
+12.06%
1 Year
-18.00%
2 Year
+11.18%
5 Year
-27.86%
10 Year
+152.00%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 10.80 10.37 7.72 7.86 6.56 7.98 4.88 3.52 2.23
Return on Capital Employed (%) 13.36 14.22 11.74 14.02 14.84 16.75 12.64 8.65 7.27
Return on Assets (%) 3.66 3.64 2.89 3.17 2.77 3.60 2.06 1.38 0.95

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 19 21 23 25 26 28 29 30 30 31
Non Curr. Liab. 4 3 3 3 3 3 10 9 7 7
Curr. Liab. 27 31 27 28 26 26 31 32 24 26
Minority Int.
Equity & Liab. 50 55 53 56 55 57 69 70 61 63
Non Curr. Assets 5 4 4 4 4 5 11 9 8 8
Curr. Assets 45 51 49 52 51 52 58 61 53 55
Misc. Exp. not W/O
Total Assets 50 55 53 56 55 57 69 70 61 63

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 51 52 51 53 53 56 56 37 44 51
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 51 52 51 53 53 56 56 37 44 52
Total Expenditure -46 -47 -47 -48 -48 -51 -50 -32 -40 -47
PBIDT 5 5 5 5 5 5 6 5 5 4
Interest -1 -2 -2 -2 -2 -2 -2 -2 -2 -2
Depreciation -1 -1 -1 -1 -1 -1 -2 -2 -2 -1
Taxation -1 -1 -1 -1 -1 -1 -1 -1 0 -1
Exceptional Items
PAT 2 2 2 2 2 2 1 1 1 1
Adjusted EPS 5 5 4 5 4 6 4 3 2 3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 0 0 -2 2 2 2 2 5
Cash Fr. Inv. -1 0 0 0 -2 -1 -1 -1 -1 0
Cash Fr. Finan. 2 -1 1 1 2 -1 -1 0 -1 -5
Net Change 2 -2 1 -1 0 0 -1 0 0 0
Cash & Cash Eqvt 3 1 2 1 1 1 0 1 1 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 44.78 44.78 44.78 44.78 44.78 44.78 44.78 44.78 44.78
Public 55.22 55.22 55.22 55.22 55.22 55.22 55.22 55.22 55.22
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 13 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations 2015 our Company has received request for the issue of duplicate share certificate through our Registrar and Transfer Agent (RTA) - M/s.Purva Sharegistry (India) Private Limited. We have issued Duplicate and Consolidated Share Certificate as per duplicate register provided by our RTA
Fri, 03 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
In pursuance of Regulation 39(3) of the SEBI (LODR) Regulations 2015 please find attach heerwith the information pertaining to loss of Share Certificate being reported by the shareholders - R01253 R01257 & M01261
Wed, 01 Mar 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vijay Majrekar & Others

Technical Scans View Details >>

Mon, 20 Mar 2023
Opening at High Opening at High
Opening at Low Opening at Low
High Increase in 1 Month High Increase in 1 Month
Close Crossing 100 SMA From Above Close Crossing 100 SMA From Above
Close Crossing 200 SMA From Above Close Crossing 200 SMA From Above

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 230,636.07 956.20 -0.5%
Divi's Laboratories Ltd. 74,303.33 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. 73,967.90 4,419.30 -0.5%
Cipla Ltd. 70,000.14 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. 61,905.77 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. 51,514.78 1,518.00 -0.3%
Zydus Lifesciences Ltd. 48,165.73 477.95 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.76 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.06 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.25 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-12 26.53 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.95 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.90 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.34 477.95 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.17 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.35 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-12 3.08 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.07 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.79 477.95 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 0.04 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 477.95 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 477.95 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 477.95 +0.4%

FAQ's On Centenial Surgical Suture Ltd.

What is Centenial Surgical share price?

Can I buy Centenial Surgical shares now?

What is the Market Cap of Centenial Surgical?

What are the key metrics to analyse Centenial Surgical?

What is the 52 Week High and Low of Centenial Surgical?

What is the trend of Centenial Surgical share price?